^{Adriax^®}

Doxorubicin hydrochloride

Product Information

Proprietary Name: Adriax®
Generic Name: Doxorubicin hydrochloride
Dosage Form: Vial
Strengths: 10 mg/5 ml, 50 mg/25 ml
Indications: Breast and Lungs cancer, Malignant Lymphomas and Leukemia

Download Leaflet

Oncology

Adriax®

Doxorubicin hydrochloride is indicated for the treatment of breast and lungs cancer, malignant lymphomas and leukemia.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.